Clinical Trials (PDQ®) - National Cancer Institute

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights

A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

Basic Trial Information
Trial Description
     Summary
     Further Trial Information
     Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II

Treatment

Active

18 to 75

Other

Haema CBF SCLC UK/AS 01
NCT00168896

Trial Description

Summary

Comparison of two combination chemotherapies in the treatment of patients with SLCL

Further Study Information

Comparison of two combination chemotherapies in the treatment of patients with SLCL

The combination chemotherapies for this study are Carboplatin plus Irinotecan versus Carboplatin plus Etoposide.

Eligibility Criteria

Inclusion Criteria:

cytological or histological proven SCLC Stage I or II at 1st diagnosis

no prior chemotherapy

measurable tumor disease

karnofsky performance 70

Exclusion Criteria:

second malignancy ( except basal cell carcinoma, CA in situ Cervix uteri)

NYHA III

chronic diarrhea, obstructive bowel syndrome

Trial Contact Information

Trial Lead Organizations/Sponsors

Charite University Hospital - Campus Virchow Klinikum

Pfizer Incorporated

Sanofi-Aventis - US - Bridgewater

Ulrich Keilholz

Principal Investigator

Ulrich Keilholz, MD		Ph: +49-30-8445-3596
		Email: ulrich.keilholz@charite.de

Alexander Schmittel, MD		Ph: +49-30-8445-3090
		Email: alexander.schmittel @charite.de

Trial Sites

Germany

Berlin

Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin

Ulrich Keilholz, MD Ph: +49-30-8445-3596

Email: ulrich.keilholz@charite.de

Alexander Schmittel, MD Ph: +49-30-8445-3090

Email: alexander.schmittel@charite.de

Ulrich Keilholz Principal Investigator

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00168896
Information obtained from ClinicalTrials.gov on May 27, 2008

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.